previous arrow
next arrow
Slider
Product Image
For the oral administration of vitamin K

Category: Vitamins

Species: Dogs, Cats

Active Ingredients: (phytonadione)

prescription required

What is Veta-K1®?

Veta-K1® Capsules contain phytonadione with excipients in an artificially colored soft gelatin shell.

Veta-K1® Capsules for oral administration possesses the same type and degree of activity as does naturally occurring vitamin K. The primary function of vitamin K is to stimulate the production via the liver of active prothrombin from a precursor protein. The mechanism by which vitamin K promotes formation of prothrombin at the molecular level has not been established.

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Indications

Veta-K1 Capsules are indicated in dogs and cats to counter hypoprothrombinemia induced by ingestion of coumarin-based compounds, common ingredients of commercial rodenticides, and other drug induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin K metabolism, (e.g. salicylates).

Benefits

Veta-K1 capsules contain 25 mg of phytonadione for the treatment of acute hypoprothrombinemia (with hemorrhage) in cats and dogs.

  • Natural
    Capsules possess the same type and degree of activity as does naturally-occurring vitamin K
  • Effective Follow-up
    Veta-K1 oral capsules are used in follow-up therapy only after administration of phytonadione injection and hospitalization is no longer required
  • Stimulative
    Vitamin K stimulates the production via the liver of active prothrombin from a precursor protein
  • Efficacious
    Drug-induced hypoprothrombinemia responds to interference with vitamin K metabolism
  • Safe
    Phytonadione will not counteract other therapy such as the anticoagulant action of heparin

Withdrawal Period

No withdrawal period

Additional Safety Information

  • To be used only as follow-up therapy only after administration of phytonadione injection and hospitalization is no longer required.
  • Repeated large doses of vitamin K1 are not warranted in hepatic disease if the response to initial therapy is unsatisfactory.
  • The smallest effective dose should be sought to minimize risk of adverse reaction.
  • Will not counteract the anticoagulant action of heparin.
  • Protect from light at all times.

Pack Size

List No.Pack SizeCase Size
1VET00650 oral capsules12